AstraZeneca is working on potential new treatment options and combinations to support lung cancer care.
Public source
Publisher name
Public post
What could the future of lung cancer care look like? -advances in biomarker testing -precision medicine therapeutics -potential new treatment options and combinations I’…
Company
AstraZeneca
- Industry
- Pharmaceutical Manufacturing
- Location
- Cambridge, GB
- Company size
- 10,001+ employees
About AstraZeneca
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio
See moreLatest activity
Latest activity from AstraZeneca
141 signals
Presence & Recognition
AstraZeneca leaders share their vision for how continued scientific progress could transform what is possible by 2040 as they head into WCLC 2026
Presence & Recognition
AstraZeneca is reflecting on the future of lung cancer care ahead of WCLC 2026.
Research & Knowledge
AstraZeneca and partner Amgen announced positive high-level Phase III results from the DeLLphi-305 trial in extensive-stage small cell lung cancer.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Pfizer
Pfizer will present at the WCLC26 conference on the analysis of the phase 3 CROWN study findings using early on-treatment AI-based imaging measures and ctDNA in patients with advanced ALK-positive NSCLC.
Research & Knowledge
GSK